Valuation
- Market cap
- 51,919,000
- Revenue TTM
- $0
- Net income TTM
- $-22,140,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 637,500
- Avg volume
- 549,572
- Day's range
- $1.57 – $1.98
- Shares out
- 26,625,000
- Stochastic %K
- 96%
- Beta
- 0.26
- Analysts
- —
- Price target
- $0.85
Company profile
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was former...
Show more
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 510 899 8800
- Website
- https://novabay.com
- Address
- 2000 Powell Street, Suite 1150, Emeryville, United States
Latest news
No headlines yet.
